{"nct_id":"NCT03616821","title":"Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis","status":"TERMINATED","status_verified_date":"2023-10","start_date":"2018-08-07","start_date_type":"ACTUAL","primary_completion_date":"2023-10-23","primary_completion_date_type":"ACTUAL","completion_date":"2023-10-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AZN"]}